Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
The purpose of this study is to assess efficacy and safety of Foscan (temoporfin) photodynamic therapy in the treatment of locally advanced perihilar bile duct carcinoma without distant metastases.
Non-curative Resectable Bile Duct Carcinoma
DRUG: Temoporfin
Rate of local response and depth of tumoricidal tissue penetration of Foscan-PDT, post treatment
Progression-free survival time, overall survival time, Before first intervention and at months 1, 3, 6, 9, 12, 18 and 24 after intervention|Toxicity using WHO criteria and criteria for local toxicity in the biliary system, Before first intervention and at months 1, 3, 6, 9, 12, 18 and 24 after intervention
The purpose of this study is to assess efficacy and safety of Foscan (temoporfin) photodynamic therapy in the treatment of locally advanced perihilar bile duct carcinoma without distant metastases.